🎉 Congratulations, once again, on your promotion to Chief Development Officer of Immunic, Werner Gladdines! Your hard work and dedication have truly paid off. This display at the Nasdaq tower in New York City is well-deserved. Here's to many more successes and milestones ahead! 👏 #Promotion #IMUX #Immunic #NasdaqListed #Nasdaq #NewYork
Immunic Therapeutics
Biotechnology Research
New York City, New York 6,237 followers
Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases
About us
Immunic (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Privacy Policy: https://imux.com/privacy-policy/
- Website
-
https://imux.com
External link for Immunic Therapeutics
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- New York City, New York
- Type
- Public Company
- Founded
- 2016
Locations
-
Primary
1200 Avenue of the Americas
Suite 200
New York City, New York 10036, US
-
Lochhamer Schlag 21
Gräfelfing, Bayern 82166, DE
Employees at Immunic Therapeutics
Updates
-
🚀 Exciting News! 🚀 🎉 We are thrilled to announce that we have strengthened our Board of Directors with the appointment of Simona Skerjanec, an experienced pharmaceutical executive and thought leader in brain health! 🙌 🌟 Simona brings three decades of global pharmaceutical expertise to our team. Her vast experience and visionary leadership in neurology and neuroimmunology will be invaluable in driving our multiple sclerosis trials forward and ultimately hopefully over the finish line. Welcome on board, Simona! 💊 ➡️ https://bit.ly/3YhtpdR Duane Nash MD JD MBA, #ThoughtLeadership #BrainHealth #Neurology #Neuroimmunology #MultipleSclerosis #MS #Immunic #IMUX #Vidofludimus
-
-
🌍 🧠 On the occasion of yesterday's World Brain Day, our Chief Scientific Officer, Dr. Hella Kohlhof, shared insights on Immunic's research and development efforts in neurological diseases. 👉 Watch the latest Proactive interview now and learn how we are making strides towards a healthier future for patients suffering from multiple sclerosis, a chronic, unpredictable disease of the central nervous system, affecting the brain, spinal cord and optic nerve. ➡️ https://bit.ly/4bXMtkx Stephen Gunnion #WBD2024 #WorldBrainDay #BrainHealthandPrevention #Brain #MultipleSclerosis #MS #Neurology #Immunic #IMUX
-
-
🧠 Today is World Brain Day 2024! 🧠 🤝 Join us in recognizing World Brain Day, focusing on brain health and prevention this year. We are delighted to support the World Federation Of Neurology in their efforts to share vital information on preventing brain diseases. Let's come together to create a future where everyone has access to preventive and therapeutic care for optimal brain health! ⚕ #WBD2024 #WorldBrainDay #brain #BrainHealthandPrevention #Immunic #IMUX #MS #MultipleScerlosis #Neurology
-
Get ready for World Brain Day 2024, next week on July 22! This year's theme highlights the unwavering commitment to preventing brain diseases by spreading awareness and sharing healthy behaviors. Join us in sparking conversations and amplifying this vital message! #WorldBrainDay #WBD2024 #BrainHealthandPrevention #brain #awareness
-
-
🏃♀️🏃♂️For the third year in a row, we once again took part in the B2Run in Munich. Our running team has grown significantly: this year, 20 Immunic employees tackled the 5k course at the Olympic Park. Most importantly, we had a fantastic time together as a team and all of us crossed the finish line! 👏 #WeRun #gemeinsamaktiv #B2RUN Infront B2Run GmbH #Munich #IMUX #Immunic
-
🌟 Yesterday, our CEO, Dr. Daniel Vitt, gave the keynote speech at the Life Science Pitch Day 2024 at the IZB - Innovation and Start-up Center Biotechnology in Munich! 🧬 Daniel shared insights on Immunic’s journey from concept stages and foundation to being a late-stage clinical phase 3 company listed on Nasdaq. 🚀 💡 Curious? Learn more about IMUX here ➡️ www.imux.com #LifeSciences #DrugDevelopment #Nasdaq HTGF | High-Tech Gründerfonds #IZB #LSPitchDay2024 #Munich #IMUX #Immunic
-
-
✨ We are excited to see the recent appointment of Jason Tardio as our new Chief Operating Officer and President displayed on the Nasdaq tower in New York City. 🏙️ Thank you, Nasdaq, for your continuous support! Congratulations, again, to Jason and welcome to the IMUX team! #IMUX #Immunic #ChiefOperatingOfficer #Nasdaq #NasdaqListed #NewYork #Grateful 🙏
-
-
🌾 News for celiac disease patients! In a phase 1b clinical trial, Immunic's drug candidate, IMU-856, showed positive effects in four main dimensions of clinical outcome in celiac disease: 🛡️ Protected gut architecture 🌟 Improved symptoms 📊 Boosted biomarker response 🍽️ Enhanced nutrient absorption Do you want to learn more? Our comprehensive presentation during Digestive Disease Week® (DDW) will give you all the insights! 🌾 💚 ➡️ https://bit.ly/3XGngaX #Gastroenterology #gut #Celiac #CeliacDisease #symptoms #biomarker #nutrient #IMU856 #Immunic #IMUX #DigestiveDiseaseWeek #DDW #DDW2024
-
-
🌾 News for celiac disease patients! In a phase 1b clinical trial, Immunic's drug candidate, IMU-856, showed positive effects in four main dimensions of clinical outcome in celiac disease: 🛡️ Protected gut architecture 🌟 Improved symptoms 📊 Boosted biomarker response 🍽️ Enhanced nutrient absorption Do you want to learn more? Our comprehensive presentation during Digestive Disease Week® (DDW) will give you all the insights! 🌾 💚 ➡️ https://bit.ly/3XGngaX #Gastroenterology #gut #Celiac #CeliacDisease #symptoms #biomarker #nutrient #IMU856 #Immunic #IMUX #DigestiveDiseaseWeek #DDW #DDW2024
-